Brief: Mynd Analytics And Emmaus Life Sciences Provide Update To Shareholders Addressing Questions Related To Merger And Spin-Off Transaction
10/01/2019 12:33
Jan 10 (Reuters) - MYnd Analytics Inc MYND.O :
* MYND ANALYTICS AND EMMAUS LIFE SCIENCES PROVIDE UPDATE TO
SHAREHOLDERS ADDRESSING QUESTIONS RELATED TO MERGER AND SPIN-OFF
TRANSACTION
* MYND ANALYTICS INC - MYND SHAREHOLDERS WILL OWN 5.9% OF
FULLY
DILUTED SHARES OF EMMAUS POST CLOSING
Source text for Eikon: ID:nGNX11W1Ny
Further company coverage: MYND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Emmaus Life Sciences
See all newsEmmaus Life Sciences Q2 revenue soars on licensing deal
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S.
Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Emmaus Life Sciences Q3 revenue falls 38%, swings to loss
Brief: Emmaus Life Sciences CFO Yasushi Nagasaki Resigns